The FDA approved a pill with a sensor that sends a digital signal to an external patch that sends a message to a phone app to confirm that a patient has taken the medication. Abilify MyCite is used treat schizophrenia, bipolar I disorder and depression.
While the manufacturer touts the ability to track ingestion of pills, the company has not made the further claim that the smart pill will actually improve patients’ compliance with their treatment regimens.
Abilify MyCite has a Boxed Warning to alert prescribers that it carries an increased risk of death among elderly patients taking antipsychotic drugs. The drug is also associated with an increased risk of suicidal thinking and behavior among younger people. Posted November 13, 2017. Via FDA.
Older patients taking antipsychotics may have an increased risk of experiencing cardiovascular disease, according to a study from the University of Buenos Aires, in Argentina. Researchers examined 1,008 patients, with a mean age of 72.4 years, taking antipsychotics from 2002 to 2007.
The researchers first divided the patients into cohorts according to the severity of metabolic side effects from the long-term antipsychotic use, grouping them as low, intermediate and high. Then they looked at cardiovascular events as related to the metabolic groups. The results showed that 19.6% of the intermediate and high groups faced a high risk of experiencing serious cardiovascular events, such as acute myocardial infarction, acute coronary syndrome, ischemic stroke or peripheral artery disease. Via September/October issue of Journal of Clinical Psychiatry.
Alanna McCatty is a recent graduate of Pace University with a degree in communications. At MedShadow, she reports on new findings and research on the side effects of prescription drugs.